Ascendis Pharma
ASND
#1291
Rank
โ‚ฌ15.36 B
Marketcap
234,31ย โ‚ฌ
Share price
1.52%
Change (1 day)
60.01%
Change (1 year)

EPS for Ascendis Pharma (ASND)

EPS in 2026 (TTM): 8,01ย โ‚ฌ

According to Ascendis Pharma 's latest financial reports the company's current EPS (TTM) is 8,08ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of -3,75ย โ‚ฌ an increase over its 2024 EPS that were of -6,23ย โ‚ฌ.

EPS history for Ascendis Pharma from 2023 to 2026

Annual EPS

Year EPS Change
2026 (TTM)8,01ย โ‚ฌ-313.66%
2025-3,75ย โ‚ฌ-39.79%
2024-6,23ย โ‚ฌ-23.17%
2023-8,10ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Akebia Therapeutics
AKBA
-0,06126ย โ‚ฌ-100.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Affimed
AFMD
-4,58ย โ‚ฌ-156.62%๐Ÿ‡ฉ๐Ÿ‡ช Germany
Advaxis
ADXS.defunct
-8,48ย โ‚ฌ-204.97%๐Ÿ‡บ๐Ÿ‡ธ USA